https://pipelinereview.com/sarepta-therapeutics-announces-initiation-of-embark-a-global-pivotal-study-of-srp-9001-a-gene-therapy-for-the-treatment-of-duchenne-muscular-dystrophy/
Sarepta Therapeutics Announces Initiation of EMBARK, a Global Pivotal Study of SRP-9001, a Gene Therapy for the Treatment of Duchenne Muscular Dystrophy